[en] The liver immune microenvironment is a key element in the development of hepatic inflammation in NAFLD. ApoA4 deficiency increases the hepatic lipid burden, insulin resistance, and metabolic inflammation. However, the effect of ApoA4 on liver immune cells and the precise immune cell subsets that exacerbate fatty liver remain elusive. The aim of this study was to profile the hepatic immune cells affected by ApoA4 in NAFL. We performed scRNA-seq on liver immune cells from WT and ApoA4-deficient mice administered a high-fat diet. Immunostaining and qRT-PCR analysis were used to validate the results of scRNA-seq. We identified 10 discrete immune cell populations comprising macrophages, DCs, granulocytes, B, T and NK&NKT cells and characterized their subsets, gene expression profiles, and functional modules. ApoA4 deficiency led to significant increases in the abundance of specific subsets, including inflammatory macrophages (2-Mφ-Cxcl9 and 4-Mφ-Cxcl2) and activated granulocytes (0-Gran-Wfdc17). Moreover, ApoA4 deficiency resulted in higher Lgals3, Ctss, Fcgr2b, Spp1, Cxcl2, and Elane levels and lower Nr4a1 levels in hepatic immune cells. These genes were consistent with human NAFLD-associated marker genes linked to disease severity. The expression of NE and IL-1β in granulocytes and macrophages as key ApoA4 targets were validate in the presence or absence of ApoA4 by immunostaining. The scRNA-seq data analyses revealed reprogramming of liver immune cells resulted from ApoA4 deficiency. We uncovered that the emergence of ApoA4-associated immune subsets (namely Cxcl9+ macrophage, Cxcl2+ macrophage and Wfdc17+ granulocyte), pathways, and NAFLD-related marker genes may promote the development of NAFL. These findings may provide novel therapeutic targets for NAFL and the foundations for further studying the effects of ApoA4 on immune cells in various diseases.
Disciplines :
Immunology & infectious disease
Author, co-author :
Liu, Xiao-Huan; National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China
Zhou, Jin-Ting; Key laboratory of Ministry of Public Health for Forensic Sciences, Western China Science & Technology Innovation Harbour, Xi'an, China
Yan, Chun-Xia; College of Forensic Medicine, Xi'an Jiaotong University Health Science Center, Xi'an, China ; Department of Pathology, Bio-Evidence Sciences Academy, The Western China Science and Technology Innovation Port, Xi'an Jiaotong University, Xi'an, China
Cheng, Cheng; Key laboratory of Ministry of Public Health for Forensic Sciences, Western China Science & Technology Innovation Harbour, Xi'an, China
Fan, Jing-Na; Key laboratory of Ministry of Public Health for Forensic Sciences, Western China Science & Technology Innovation Harbour, Xi'an, China
Xu, Jing; Division of Endocrinology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China
Zheng, Qiangsun; Division of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China
Bai, Qiang ; Université de Liège - ULiège > Département des sciences fonctionnelles (DSF)
Li, Zongfang; National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China
Li, Shengbin; Key laboratory of Ministry of Public Health for Forensic Sciences, Western China Science & Technology Innovation Harbour, Xi'an, China
Li, Xiaoming; National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China
Language :
English
Title :
Single-cell RNA sequencing reveals a novel inhibitory effect of ApoA4 on NAFL mediated by liver-specific subsets of myeloid cells.
NSCF - National Natural Science Foundation of China Natural Science Foundation of Shaanxi Province
Funding text :
This work was supported by grants from the National Natural Science Foundation of China (No. 81770798) and Natural Science Foundation of Shaanxi Province (No.2020JM-405).
Huang DQ El-Serag HB Loomba R. Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol (2021) 18(4):223–38. doi: 10.1038/s41575-020-00381-6
Sutti S Albano E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol (2020) 17(2):81–92. doi: 10.1038/s41575-019-0210-2
Nati M Haddad D Birkenfeld AL Koch CA Chavakis T Chatzigeorgiou A. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord (2016) 17(1):29–39. doi: 10.1007/s11154-016-9339-2
Remmerie A Martens L Thoné T Castoldi A Seurinck R Pavie B et al. Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver. Immunity (2020) 53(3):641–57. doi: 10.1016/j.immuni.2020.08.004
Krenkel O Tacke F. Macrophages in nonalcoholic fatty liver disease: A role model of pathogenic immunometabolism. Semin Liver Dis (2017) 37(3):189–97. doi: 10.1055/s-0037-1604480
Li X Liu X Zhang Y Cheng C Li Z. Hepatoprotective effect of apolipoprotein A4 against carbon tetrachloride induced acute liver injury through mediating hepatic antioxidant and inflammation response in mice. Biochem Biophys Res Commun (2020) 534(2):659–65. doi: 10.1016/j.bbrc.2020.11.024
Lamina C Friedel S Coassin S Rueedi R Yousri NA Seppälä I et al. A genome-wide association meta-analysis on apolipoprotein a-IV concentrations. Hum Mol Genet (2016) 25(16):3635–46. doi: 10.1093/hmg/ddw211
Cheng CW Chang CC Chen HW Lin CY Chen JS. Serum ApoA4 levels predicted the progression of renal impairment in T2DM. Eur J Clin Invest (2018) 48(6):e12937. doi: 10.1111/eci.12937
Peng J Li XP. Apolipoprotein a-IV: A potential therapeutic target for atherosclerosis. Prostaglandins other Lipid Mediators (2018) 139:87–92. doi: 10.1016/j.prostaglandins.2018.10.004
Blencowe M Ahn IS Saleem Z Luk H Cely I Mäkinen VP et al. Gene networks and pathways for plasma lipid traits via multitissue multiomics systems analysis. J Lipid Res (2021) 62:100019. doi: 10.1194/jlr.RA120000713
Wang Z Wang L Zhang Z Feng L Song X Wu J. Apolipoprotein a-IV involves in glucose and lipid metabolism of rat. Nutr Metab (2019) 16:41. doi: 10.1186/s12986-019-0367-2
Cheng C Liu XH He J Gao J Zhou JT Fan JN. Apolipoprotein A4 restricts diet-induced hepatic steatosis via SREBF1-mediated lipogenesis and enhances IRS-PI3K-Akt signaling. Mol Nutr Food Res (2022) 66(18):e2101034. doi: 10.1002/mnfr.202101034
Xiong X Kuang H Ansari S Liu T Gong J Wang S et al. Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis. Mol Cell (2019) 75(3):644–60. doi: 10.1016/j.molcel.2019.07.028
Li X Xu M Wang F Kohan AB Haas MK Yang Q et al. Apolipoprotein a-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1. J Biol Chem (2014) 289(4):2396–404. doi: 10.1074/jbc.M113.511766
Zhao J Zhang S Liu Y He X Zhang Z. Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human. Cell Discovery (2020) 6:22. doi: 10.1038/s41421-020-0157-z
Yu G Wang LG Han Y He QY. ClusterProfiler: an r package for comparing biological themes among gene clusters. OMICS (2012) 16(5):284–7. doi: 10.1089/omi.2011.0118
Subramanian A Tamayo P Mootha VK Mukherjee S Ebert BL Gillette MA et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U.S.A. (2005) 102(43):15545–50. doi: 10.1073/pnas.0506580102
Jin S Guerrero-Juarez CF Zhang L Chang I Nie Q. Inference and analysis of cell-cell communication using CellChat. Nat Commun (2021) 12(1):1088. doi: 10.1038/s41467-021-21246-9
Wang F Kohan AB Kindel TL Corbin KL Nunemaker CS Obici S et al. Apolipoprotein a-IV improves glucose homeostasis by enhancing insulin secretion. Proc Natl Acad Sci U.S.A. (2012) 109(24):9641–6. doi: 10.1073/pnas.1201433109
Cochain C Vafadarnejad E Arampatzi P Jaroslav P Winkels H Ley K et al. Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis. Circ Res (2018) 122(12):1661–74. doi: 10.1161/CIRCRESAHA.117.312509
Zhang Q He Y Luo N Patel SJ Zhang Z. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell (2019) 179(4):829–45. doi: 10.1016/j.cell.2019.10.003
Heymann F Tacke F. Immunology in the liver–from homeostasis to disease. Nat Rev Gastroenterol Hepatol (2016) 13(2):88–110. doi: 10.1038/nrgastro.2015.200
Waddell LA Lefevre L Bush SJ Raper A Young R. ADGRE1 (EMR1, F4/80) is a rapidly-evolving gene expressed in mammalian monocyte-macrophages. Front Immunol (2018) 9:2246. doi: 10.3389/fimmu.2018.02246
Gundra UM Girgis NM Ruckerl D Jenkins S Loke PN. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood (2014) 123(20):e110–122. doi: 10.1182/blood-2013-08-520619
Bassez A Vos H Dyck LV Floris G Lambrechts D. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat Med (2021) 27(5):1–13. doi: 10.1038/s41591-021-01323-8
Seidman JS Troutman TD Sakai M Gola A Spann NJ Bennett H et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity (2020) 52(6):1057–74. doi: 10.1016/j.immuni.2020.04.001
Wu K Lin K Li X Yuan X Xu D Ni P et al. Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment. Front Immunol (2020) 11:1731. doi: 10.3389/fimmu.2020.01731
Furuhashi M Ogura M Matsumoto M Yuda S Muranaka A Kawamukai M et al. Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages. Sci Rep (2017) 7(1):217. doi: 10.1038/s41598-017-00177-w
Narayana SK Helbig KJ Mccartney EM Eyre NS Bull RA Eltahla A et al. The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis c virus entry. J Biol Chem (2015) 290(43):25946–59. doi: 10.1074/jbc.M115.657346
Xie X Shi Q Wu P Zhang X Luo HR. Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection. Nat Immunol (2020) 21(9):1119–33. doi: 10.1038/s41590-020-0736-z
Peipei Y Marcovecchio P Blatchley A Padgett L Hedrick CC. Identification of an early unipotent neutrophil progenitor with pro-tumoral activity in mouse and human bone marrow. Cell Rep (2018) 24(9):2329–41. doi: 10.1016/j.celrep.2018.07.097
Van Der Windt DJ Sud V Zhang H Varley PR Goswami J Yazdani HO et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology (2018) 68(4):1347–60. doi: 10.1002/hep.29914
Lefere S Devisscher L Tacke F. Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: Opportunities and challenges. Expert Opin Investig Drugs (2020) 29(2):89–92. doi: 10.1080/13543784.2020.1718106
Gadd VL Skoien R Powell EE Fagan KJ Winterford C Horsfall L et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology (2014) 59(4):1393–405. doi: 10.1002/hep.26937
Tilg H Moschen AR Szabo G. Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology (2016) 64(3):955–65. doi: 10.1002/hep.28456
Kriss M Golden-Mason L Kaplan J Mirshahi F Setiawan VW Sanyal AJ et al. Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development. PloS One (2020) 15(7):e0236353. doi: 10.1371/journal.pone
Achyut BR Yang L. Transforming growth factor-b in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology (2011) 141(4):1167–78. doi: 10.1053/j.gastro.2011.07.048
Jenkins SJ Ruckerl D Thomas GD Hewitson JP Duncan S Brombacher F et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J Exp Med (2013) 210(11):2477–91. doi: 10.1084/jem.20121999
Wajant H Siegmund D. TNFR1 and TNFR2 in the control of the life and death balance of macrophages. Front Cell Dev Biol (2019) 7:91. doi: 10.3389/fcell.2019.00091
Hu C Chu C Liu L Wang CB Jin S Yang RL et al. Dissecting the microenvironment around biosynthetic scaffolds in murine skin wound healing. Sci Adv (2021) 7(22):eabf0787. doi: 10.1126/sciadv.abf0787
Locatelli I Sutti S Jindal A Vacchiano M Bozzola C Reutelingsperger C et al. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. Hepatology (2014) 60(2):531–44. doi: 10.1002/hep.27141
Metzemaekers M Gouwy M Proost P. Neutrophil chemoattractant receptors in health and disease: double-edged swords. Cell Mol Immunol (2020) 17(5):433–50. doi: 10.1038/s41423-020-0412-0
Friedman SL Neuschwander-Tetri BA Mary R Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med (2018) 24(7):908–22. doi: 10.1038/s41591-018-0104-9
Krenkel O Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol (2020) 17(5):306–21. doi: 10.1038/nri.2017.11
Alisi A Carpino G Oliveira FL Panera N Nobili V Gaudio E. The role of tissue macrophage-mediated inflammation on NAFLD pathogenesis and its clinical implications. Mediators Inflammation (2017) 2017:8162421. doi: 10.1155/2017/8162421
Hu Z Murakami T Tamura H Reich J Kuwahara-Arai K Iba T et al. Neutrophil extracellular traps induce IL-1β production by macrophages in combination with lipopolysaccharide. Int J Mol Med (2017) 39(3):549–58. doi: 10.3892/ijmm.2017.2870
Talukdar S Da YO Bandyopadhyay G Li D Xu J Mcnelis J et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med (2012) 18(9):1407–12. doi: 10.1038/nm.2885
Herdendorf TJ Stapels DAC Rooijakkers SHM Geisbrecht BV. Local structural plasticity of the staphylococcus aureus evasion protein EapH1 enables engagement with multiple neutrophil serine proteases. J Biol Chem (2020) 295(22):7753–62. doi: 10.1074/jbc.RA120.013601
Toonen EJM Mirea AM Tack CJ Stienstra R Ballak DB Diepen JV et al. Activation of proteinase 3 contributes to non-alcoholic fatty liver disease (NAFLD) and insulin resistance. Mol Med (2016) 22(1):202–14. doi: 10.2119/molmed.2016.00033
Mansuy-Aubert V Zhou QL Xie X Gong Z Huang JY Khan AR et al. Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metab (2013) 17(4):534–48. doi: 10.1016/j.cmet.2013.03.005
Li X Wang F Xu M Howles P Tso P. ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-akt signaling. Sci Rep (2017) 7:41289. doi: 10.1038/srep41289
Hanna RN Carlin LM Hubbeling HG Nackiewicz D Green AM Punt JA et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C– monocytes. Nat Immunol (2011) 12(8):778–85. doi: 10.1038/ni.2063
Nus M Basatemur G Galan M Cros-Brunsó L Zhao TX Masters L et al. NR4A1 deletion in marginal zone b cells exacerbates atherosclerosis in mice-brief report. Arterioscler Thromb Vasc Biol (2020) 40(11):2598–604. doi: 10.1161/ATVBAHA.120.314607
Qu J Fourman S Fitzgerald M Liu M Nair S Oses-Prieto J et al. Low-density lipoprotein receptor-related protein 1 (LRP1) is a novel receptor for apolipoprotein A4 (APOA4) in adipose tissue. Sci Rep (2021) 11(1):13289. doi: 10.1038/s41598-021-92711-0
